Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  IQVIA Holdings Inc.    IQV

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/14/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
164.32(c) 165.42(c) 164.39(c) 164.14(c) 163.43(c) Last
2 967 361 1 436 201 1 070 909 1 574 310 958 139 Volume
-0.89% +0.67% -0.62% -0.15% -0.43% Change
More quotes
Financials (USD)
Sales 2020 11 879 M
EBIT 2020 2 277 M
Net income 2020 449 M
Debt 2020 10 067 M
Yield 2020 -
Sales 2021 12 803 M
EBIT 2021 2 500 M
Net income 2021 624 M
Debt 2021 9 737 M
Yield 2021 -
P/E ratio 2020 70,6x
P/E ratio 2021 49,2x
EV / Sales2020 3,50x
EV / Sales2021 3,22x
Capitalization 31 512 M
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial... 
Sector
Biotechnology & Medical Research
Calendar
04/06 | 09:00amShareholder meeting
More about the company
Surperformance© ratings of IQVIA Holdings Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on IQVIA HOLDINGS INC.
02/20IQVIA : Launches Avacare Clinical Research Network to Increase Patients' Clinica..
BU
02/18IQVIA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
02/13IQVIA : Announces Repurchase of Common Stock
BU
02/12IQVIA : 4Q Earnings Snapshot
AQ
02/12IQVIA HOLDINGS INC. : Results of Operations and Financial Condition, Financial S..
AQ
02/12IQVIA : Reports Fourth-Quarter and Full-Year 2019 Results Issues First-Quarter a..
BU
02/07IQVIA HOLDINGS INC. : annual earnings release
02/03IQVIA : Launches FluSTAR Mobile App to Help Consumers Manage Their Health During..
BU
01/30IQVIA : 's Breakthrough Natural Language Processing Platform Receives 2019 Fierc..
BU
01/29IQVIA : to Announce Fourth-Quarter and Full-Year 2019 Results and Issue 2020 Gui..
BU
01/23IQVIA : AP-HP, Europe's Leading Clinical Research Center, and IQVIA Collaborate ..
BU
01/21IQVIA : Named to FORTUNE's 2020 List of “World's Most Admired Companies&rd..
BU
2019Drugmakers Turn to Data Mining to Avoid Expensive, Lengthy Drug Trials
DJ
2019IQVIA : AstraZeneca Selects IQVIA OCE to Help Further its Digital Focus
BU
2019IQVIA HOLDINGS INC. : Entry into a Material Definitive Agreement, Creation of a ..
AQ
More news
News in other languages on IQVIA HOLDINGS INC.
02/07IQVIA HOLDINGS INC. : Veröffentlichung des Jahresergebnisses
02/07IQVIA HOLDINGS INC. : publication des résultats annuels
More news
Sector news : Biotechnology & Medical Research - NEC
02/20Anglo American Discloses All Mine Deaths in Industry Shift--Update
DJ
02/20Anglo American Discloses All Mine Deaths in Industry Shift -- Update
DJ
02/20Anglo American Discloses All Mine Deaths in Industry Shift
DJ
02/20GlaxoSmithKline Invests $50 Million in Biotech Startup's Cell-Therapy Program
DJ
02/19Five Prime Therapeutics In License Agreement with Seattle Genetics
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | IQV | US46266C1053 | MarketScreener
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Average target price 182,65  $
Last Close Price 163,43  $
Spread / Highest target 22,4%
Spread / Average Target 11,8%
Spread / Lowest Target -17,4%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
James Grant Berkshire Senior Vice President-Business Operations
Michael R. McDonnell Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Jonathan J. Coslet Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.5.77%31 512
LONZA GROUP19.03%31 846
SEATTLE GENETICS, INC.2.40%20 154
CELLTRION, INC.--.--%19 564
INCYTE CORPORATION-5.21%17 535
GALAPAGOS33.78%17 526